Skip to main content
WHANIN PHARM CO.,LTD logo

WHANIN PHARM CO.,LTD — Investor Relations & Filings

Ticker · 016580 ISIN · KR7016580003 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2025-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 016580

About WHANIN PHARM CO.,LTD

https://www.whanin.com/?lang=eng

WHANIN PHARM CO.,LTD. is a pharmaceutical company that develops, manufactures, and sells a range of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), with a particular focus on neuropsychiatric treatments such as anti-psychotics and CNS stimulants. In addition to its core CNS portfolio, Whanin Pharm's product line includes pharmaceuticals for the cardiovascular and gastrointestinal systems, antibiotics, and vitamin supplements. The company also provides development and manufacturing services for finished drug formulations.

Recent filings

Filing Released Lang Actions
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Whanin Pharm Co., Ltd. covering the period from 2025.01.01 to 2025.03.31. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a formal announcement of preliminary financial results (영업(잠정)실적) for the first quarter of 2025. It provides key financial highlights such as revenue, operating profit, and net income in a structured table format. This is a standard initial earnings release announcement, which fits the definition of an Earnings Release (ER). Q1 2025
2025-04-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of an outside director (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of board management changes, specifically the appointment of a new outside director, which is classified as MANG (Board/Management Information).
2025-03-21 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM) for Hwanin Pharmaceutical. It details the approval of financial statements, dividend declarations, and the election of directors and audit committee members. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Hwanin Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper) and key financial data (assets, liabilities, revenue, profit) for the fiscal year ending 2024-12-31. While it contains financial data, it is a formal notification of the audit report's submission to the regulatory body (KRX), which is a standard requirement for audit reporting in South Korea. It fits the 'Audit Report / Information' category as it specifically details the audit results and auditor information. FY 2024
2025-03-13 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Whan In Pharm Co., Ltd. for the 43rd fiscal year (2024.01.01-2024.12.31). It contains comprehensive financial statements, management discussion and analysis, governance information, and operational details. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, providing a full yearly overview of company activity and financial performance. FY 2024
2025-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.